Implementation of preemptive DNA sequence–based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study
- 21 March 2022
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 24 (5) , 1062-1072
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Integrating Pharmacogenomics into Clinical Practice: Promise vs RealityThe American Journal of Medicine, 2016
- Implementation of Clinical Pharmacogenomics within a Large Health System: From Electronic Health Record Decision Support to Consultation ServicesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2016
- Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialtiesPharmacogenomics and Personalized Medicine, 2014
- A general framework for estimating the relative pathogenicity of human genetic variantsNature Genetics, 2014
- Preemptive Genotyping for Personalized Medicine: Design of the Right Drug, Right Dose, Right Time—Using Genomic Data to Individualize Treatment ProtocolMayo Clinic Proceedings, 2014
- Primary care physicians' knowledge of and experience with pharmacogenetic testingClinical Genetics, 2012
- Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide SurveyClinical Pharmacology & Therapeutics, 2012
- Clan Genomics and the Complex Architecture of Human DiseaseCell, 2011
- Genomics and Drug ResponseNew England Journal of Medicine, 2011
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithmNature Protocols, 2009